|
ISIN No
|
INE351Y01019
|
BSE Code / NSE Code
|
/
|
Book Value (Rs.)
|
179.17
|
Face Value
|
10.00
|
|
Bookclosure
|
26/03/2025
|
52Week High
|
2214
|
EPS
|
42.02
|
P/E
|
41.17
|
|
Market Cap.
|
1746.36 Cr.
|
52Week Low
|
1143
|
P/BV / Div Yield (%)
|
9.66 / 0.00
|
Market Lot
|
105.00
|
|
Security Type
|
Other
|
|
The company history sections lists out major chronological events that happened to the company.
| The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24, 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969.
KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY
2005
-Incorporation of the Company as Beta Drugs Private Limited
2014
-Vijay Kumar Batra, existing promoter took over the Company
2015
-ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules
-Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh
2016
-Certificate of Good Manufacturing Practice from Republic of Kenya
2017
-Conversion of Company into Public Limited Company.
2024
-The Company Earns Forbes Asia ""Best Under a Billion"" 2024 Award for Third Consecutive Year,
|